|
|
|
Lung Transplant
Lung transplant replaces one or both diseased lungs with the lungs from a healthy person. Some chronic illnesses result in destruction of the lung tissue. These include emphysema or alpha-one-antitrypsin deficiency (low levels of lung-protecting protein). Other diseases result in scarring of the lung and may interfere with oxygen levels, including pulmonary fibrosis, pulmonary hypertension, sarcoidosis, eosinophilic granuloma (presence of cysts in one or more bones) and lymphangioleiomyomatosis (abnormal cells growing throughout the lungs and blocking airways). Additionally, some diseases such as bronchiectasis (injury to the lung’s airway walls) and cystic fibrosis result in chronic infection that can be effectively treated with lung transplant. Most patients require only a single lung transplant. Patients with chronic lung infections often require a double lung transplantation. For many patients, this procedure is an opportunity for a healthier quality of life. There are some conditions for which transplantation is not appropriate. Other health problems can increase the risk of this procedure, therefore, a lung transplant is not for everyone.
Usually transplant patients have no medical or surgical alternative other than transplantation. Currently, single lung transplantation is the most commonly performed procedure.
Cadaveric donor – A cadaveric donor is a person with irreversible brain damage or who has been declared brain-dead and whose family has agreed to donate the organs for transplantation. The distribution of cadaveric donor lungs is managed by regional organ procurement agencies, all of which are closely regulated by the United States government. Potential recipients are registered on both national and regional waiting lists. Recipients for donor lungs are selected based on the closest blood type and height match, as well as length of time on the waiting list. There are many issues to consider in determining the best donor option for you. The transplant team will work with you in evaluating all aspects of each option, including consideration of your medical situation and tissue compatibility needs. Patients referred to our Transplant Center undergo a complete medical assessment specific to their needs. This assessment may include:
In addition, lung transplant patients must be nonsmoking for the rest of their lives. Patients are also screened for anticipated compliance, support system availability and emotional stability. Financial coverage for the transplant and aftercare is also confirmed.
Overall, the chance of living one year after lung transplantation is 77 percent. After the first year, patients who consistently take their medication and visit their physician should continue to enjoy the benefits of transplant for a long time.
The transplant team consists of doctors, nurses, social workers, dietitians, pharmacists, financial counselors and other healthcare professionals working together to care for you throughout the transplant process. For a listing of other members of the transplant teams, please go to the main University of Kentucky employee directory.
The combined heart/lung surgical procedure is similar to the heart transplant operation. The operation is more complex, however, and the one-year survival rate is approximately 60 percent.
|
|
|
To make an appointment or find a physician, please call UK HealthCare at 859-257-1000 or toll free 1-800-333-8874. Send us Comments and Corrections.
Terms, Conditions & Privacy and Accessibility Statements.
|